Skip to content

General Drug Use-Results Survey of COMLEX OTIC SOLUTION 1.5%

General Drug Use-Results Survey of COMLEX OTIC SOLUTION 1.5%

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT2031240141
Enrollment
300
Registered
2024-06-04
Start date
2024-06-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otitis externa, Chronic otitis media, and Acute otitis media

Interventions

none

Sponsors

CEOLIA Pharma.Co.Ltd Pharmacovigilance Office
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients treated with this drug for otitis externa, chronic otitis media, and acute otitis media

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
Examine the safety of the drug when administered under routine medical care. In conjunction, the efficacy of this drug also be examined.

Contacts

Public ContactPharmacovigilance Office CEOLIA Pharma.Co.Ltd

CEOLIA Pharma.Co.Ltd

2030_ceo@ceolia.co.jp+81-3-5829-5878

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026